Delek US price target raised to $21 from $19 at Wells Fargo

Wells Fargo analyst Roger Read raised the firm’s price target on Delek US to $21 from $19 and keeps an Underweight rating on the shares. The firm notes that while continued focus on structural and cost improvements create positive momentum into FY24, ongoing restructuring overhang and the awaited for sum-of-the-parts unlock keep Wells bearish for now.